(NASDAQ: CVRX) Cvrx's forecast annual revenue growth rate of 19.01% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.97%, and it is also forecast to beat the US market's average forecast revenue growth rate of 14.06%.
Cvrx's revenue in 2026 is $56,651,000.On average, 9 Wall Street analysts forecast CVRX's revenue for 2026 to be $1,746,485,538, with the lowest CVRX revenue forecast at $1,657,999,603, and the highest CVRX revenue forecast at $1,815,106,209. On average, 9 Wall Street analysts forecast CVRX's revenue for 2027 to be $2,055,436,427, with the lowest CVRX revenue forecast at $1,892,646,515, and the highest CVRX revenue forecast at $2,254,378,488.
In 2028, CVRX is forecast to generate $2,556,567,294 in revenue, with the lowest revenue forecast at $2,191,756,863 and the highest revenue forecast at $2,878,752,922.